During the past decade, Karadeniz Technical University Medical Faculty Farabi Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Karadeniz Technical University Medical Faculty Farabi Hospital" #1 sponsor was "Camurus AB" with 2 trials, followed by "Diskapi Teaching and Research Hospital" with 2 trials sponsored, "Karadeniz Technical University" with 2 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Karadeniz Technical University Medical Faculty Farabi Hospital" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Innovative Medicines Initiative (IMI) COMBACTE-CARE (EU)" with 1 trials as a collaborator and "Turkish Society of Anesthesiology and Reanimation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Karadeniz Technical University Medical Faculty Farabi Hospital" are "Acromegaly" (2 trials), "Blood Transfusion" (2 trials), "Epilepsy, Partial Seizures" (2 trials), "Anemia" (1 trials) and "Blood Loss Anemia" (1 trials). Many other conditions were trialed in "Karadeniz Technical University Medical Faculty Farabi Hospital" in a lesser frequency.

Most popular intervention types in "Karadeniz Technical University Medical Faculty Farabi Hospital" are "Drug" (5 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Blood transfusion" (2 trials), "CAM2029 (octreotide subcutaneous depot)" (2 trials), "ATM-AVI" (1 trials), "COL" (1 trials) and "Control" (1 trials). Other intervention names were less common.

The vast majority of trials in "Karadeniz Technical University Medical Faculty Farabi Hospital" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Karadeniz Technical University Medical Faculty Farabi Hospital". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Karadeniz Technical University Medical Faculty Farabi Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Karadeniz Technical University Medical Faculty Farabi Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".